This article explores 6-base genome sequencing and how it is empowering researchers to expand their studies to include both genetic and epigenetic data.

GenAssist’s IND application for GEN6050X receives US FDA clearance, a globally first-in-class base editing drug for duchenne muscular dystrophy: Suzhou, China Friday, March 7, 2 ...

On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is ...

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans. Now, researchers at Harvard University have designed a new class ...